Bank Of New York Mellon Corp Relmada Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $403,971 - $6.67 Million	186,162 New	186,162 $649,000
Q3 2022 Nov 14, 2022	SELL	$18.3 - $37.02 $496,716 - $1 Million	-27,143 Reduced 11.22%	214,876 $7.96 Million
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $82,599 - $151,882	5,006 Added 2.11%	242,019 $4.6 Million
Q1 2022 May 11, 2022	BUY	$16.72 - $26.99 $403,804 - $651,835	24,151 Added 11.35%	237,013 $6.4 Million
Q4 2021 Feb 11, 2022	BUY	$16.93 - $26.82 $252,731 - $400,368	14,928 Added 7.54%	212,862 $4.8 Million
Q3 2021 Nov 12, 2021	SELL	$21.86 - $34.77 $26,013 - $41,376	-1,190 Reduced 0.6%	197,934 $5.19 Million
Q2 2021 Aug 11, 2021	BUY	$29.55 - $39.15 $283,089 - $375,057	9,580 Added 5.05%	199,124 $6.37 Million
Q1 2021 May 13, 2021	BUY	$31.52 - $39.28 $769,876 - $959,414	24,425 Added 14.79%	189,544 $6.67 Million
Q4 2020 Feb 09, 2021	SELL	$29.88 - $39.8 $369,914 - $492,723	-12,380 Reduced 6.97%	165,119 $5.3 Million
Q3 2020 Nov 12, 2020	BUY	$34.42 - $43.78 $1.55 Million - $1.97 Million	45,068 Added 34.03%	177,499 $6.68 Million
Q2 2020 Aug 12, 2020	BUY	$31.59 - $49.98 $1.08 Million - $1.71 Million	34,287 Added 34.94%	132,431 $5.93 Million
Q1 2020 May 06, 2020	SELL	$23.78 - $50.12 $106,296 - $224,036	-4,470 Reduced 4.36%	98,144 $3.35 Million
Q4 2019 Feb 14, 2020	BUY	$10.1 - $47.18 $1.04 Million - $4.84 Million	102,614 New	102,614 $4 Million

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.